These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35134032)

  • 1. Early Administration of Remdesivir and Intensive Care Unit Admission in Hospitalized Pregnant Individuals With Coronavirus Disease 2019 (COVID-19).
    Eid J; Abdelwahab M; Colburn N; Day S; Cackovic M; Rood KM; Costantine MM
    Obstet Gynecol; 2022 Apr; 139(4):619-621. PubMed ID: 35134032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
    Hussain Alsayed HA; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Hussain AAS; Hamid Q; Halwani R
    PLoS One; 2021; 16(10):e0258643. PubMed ID: 34699552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients.
    Platzer M; Totschnig D; Karolyi M; Clodi-Seitz T; Wenisch C; Zoufaly A
    Wien Klin Wochenschr; 2024 Aug; 136(15-16):458-464. PubMed ID: 38884783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
    Burwick RM; Yawetz S; Stephenson KE; Collier AY; Sen P; Blackburn BG; Kojic EM; Hirshberg A; Suarez JF; Sobieszczyk ME; Marks KM; Mazur S; Big C; Manuel O; Morlin G; Rose SJ; Naqvi M; Goldfarb IT; DeZure A; Telep L; Tan SK; Zhao Y; Hahambis T; Hindman J; Chokkalingam AP; Carter C; Das M; Osinusi AO; Brainard DM; Varughese TA; Kovalenko O; Sims MD; Desai S; Swamy G; Sheffield JS; Zash R; Short WR
    Clin Infect Dis; 2021 Dec; 73(11):e3996-e4004. PubMed ID: 33031500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study.
    Ryu BH; Lee JY; Lee SH
    Medicine (Baltimore); 2024 Jul; 103(29):e39035. PubMed ID: 39029053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
    Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
    J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia.
    Nasrallah S; Nguyen AQ; Hitchings L; Wang JQ; Hamade S; Maxwell GL; Khoury A; Gomez LM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5970-5977. PubMed ID: 33771091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Critically Ill Pregnant Patients with COVID-19 Infection in a Rural State.
    Pagan ME; Ramseyer AM; Whitcombe DD; Doiron TE; Magann EF; Sandlin AT; Hughes DS
    Am J Perinatol; 2022 Jan; 39(2):165-171. PubMed ID: 34775583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy and Safety of Remdesivir among Hospitalised Adult Patients with RT PCR Confirmed COVID 19 Requiring ICU Care in Kalyana Karnataka.
    Waddankeri S; Hesarur SS; Hiremath SS; A S; Ar S; Raikod BP; Kinagi S; Biradar S; Belli B; Melkundi S; Singh G
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?
    Boglione L; Meli G; Poletti F; Rostagno R; Moglia R; Cantone M; Esposito M; Scianguetta C; Domenicale B; Di Pasquale F; Borrè S
    QJM; 2022 Jan; 114(12):865-871. PubMed ID: 34850210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.
    Tamura S; Kaki T; Niwa M; Yamano Y; Kawai S; Yamashita Y; Tanaka H; Saito Y; Kajimoto Y; Koizumi Y; Yamaue H; Nakao N; Nojiri T; Hironishi M
    Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056426
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
    Wong CKH; Lau KTK; Au ICH; Xiong X; Lau EHY; Cowling BJ
    Clin Infect Dis; 2022 Apr; 74(8):1450-1458. PubMed ID: 34265054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of remdesivir for COVID-19 in pregnancy and lactation.
    Jorgensen SCJ; Davis MR; Lapinsky SE
    J Antimicrob Chemother; 2021 Dec; 77(1):24-30. PubMed ID: 34427297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
    Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA;
    N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19.
    Falcone M; Suardi LR; Tiseo G; Barbieri C; Giusti L; Galfo V; Forniti A; Caroselli C; Della Sala L; Tempini S; Okoye C; Monzani F; Menichetti F
    Clin Ther; 2022 Mar; 44(3):364-373. PubMed ID: 35120742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel.
    Goldberg E; Ben Zvi H; Sheena L; Sofer S; Krause I; Sklan EH; Shlomai A
    Clin Microbiol Infect; 2021 Jun; 27(6):917.e1-917.e4. PubMed ID: 33705849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19.
    Finn A; Jindal A; Andrea SB; Selvaraj V; Dapaah-Afriyie K
    Am J Med Sci; 2022 May; 363(5):403-410. PubMed ID: 35151637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.